nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenobarbital—CYP1B1—Mitoxantrone—sarcoma	0.0642	0.0722	CbGbCtD
Phenobarbital—ABCC3—Vincristine—sarcoma	0.0511	0.0575	CbGbCtD
Phenobarbital—ABCC1—Dactinomycin—sarcoma	0.051	0.0573	CbGbCtD
Phenobarbital—CYP2B6—Thiotepa—sarcoma	0.0499	0.0562	CbGbCtD
Phenobarbital—ABCC3—Etoposide—sarcoma	0.0468	0.0527	CbGbCtD
Phenobarbital—ABCC1—Mitoxantrone—sarcoma	0.0456	0.0513	CbGbCtD
Phenobarbital—ABCB11—Vincristine—sarcoma	0.0442	0.0497	CbGbCtD
Phenobarbital—ABCC1—Epirubicin—sarcoma	0.0369	0.0415	CbGbCtD
Phenobarbital—CYP1A1—Dacarbazine—sarcoma	0.0363	0.0409	CbGbCtD
Phenobarbital—ABCC3—Doxorubicin—sarcoma	0.032	0.036	CbGbCtD
Phenobarbital—ABCC1—Vincristine—sarcoma	0.0314	0.0353	CbGbCtD
Phenobarbital—ABCC1—Etoposide—sarcoma	0.0288	0.0324	CbGbCtD
Phenobarbital—CYP2E1—Dacarbazine—sarcoma	0.028	0.0316	CbGbCtD
Phenobarbital—CYP1B1—Doxorubicin—sarcoma	0.0276	0.0311	CbGbCtD
Phenobarbital—ABCB11—Doxorubicin—sarcoma	0.0276	0.0311	CbGbCtD
Phenobarbital—ABCC2—Vincristine—sarcoma	0.0232	0.0261	CbGbCtD
Phenobarbital—CYP2E1—Mitoxantrone—sarcoma	0.0218	0.0245	CbGbCtD
Phenobarbital—ABCC2—Etoposide—sarcoma	0.0213	0.024	CbGbCtD
Phenobarbital—ABCC1—Doxorubicin—sarcoma	0.0196	0.0221	CbGbCtD
Phenobarbital—CYP1A2—Dacarbazine—sarcoma	0.0162	0.0183	CbGbCtD
Phenobarbital—CYP3A7—Vincristine—sarcoma	0.0155	0.0175	CbGbCtD
Phenobarbital—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.0155	0.0175	CbGbCtD
Phenobarbital—CYP3A4—Thiotepa—sarcoma	0.0153	0.0173	CbGbCtD
Phenobarbital—ABCC2—Doxorubicin—sarcoma	0.0145	0.0163	CbGbCtD
Phenobarbital—CYP2E1—Etoposide—sarcoma	0.0137	0.0154	CbGbCtD
Phenobarbital—ABCB1—Dactinomycin—sarcoma	0.0123	0.0138	CbGbCtD
Phenobarbital—CYP3A5—Vincristine—sarcoma	0.0116	0.0131	CbGbCtD
Phenobarbital—ABCB1—Mitoxantrone—sarcoma	0.011	0.0124	CbGbCtD
Phenobarbital—CYP3A5—Etoposide—sarcoma	0.0107	0.012	CbGbCtD
Phenobarbital—CYP2C8—Etoposide—sarcoma	0.0103	0.0115	CbGbCtD
Phenobarbital—CYP2B6—Doxorubicin—sarcoma	0.00923	0.0104	CbGbCtD
Phenobarbital—CYP1A2—Etoposide—sarcoma	0.00794	0.00893	CbGbCtD
Phenobarbital—ABCB1—Vincristine—sarcoma	0.00757	0.00852	CbGbCtD
Phenobarbital—ABCB1—Etoposide—sarcoma	0.00694	0.00781	CbGbCtD
Phenobarbital—CYP3A4—Mitoxantrone—sarcoma	0.00659	0.00742	CbGbCtD
Phenobarbital—ABCB1—Doxorubicin—sarcoma	0.00473	0.00533	CbGbCtD
Phenobarbital—CYP3A4—Vincristine—sarcoma	0.00454	0.00511	CbGbCtD
Phenobarbital—CYP3A4—Etoposide—sarcoma	0.00416	0.00468	CbGbCtD
Phenobarbital—CYP3A4—Doxorubicin—sarcoma	0.00284	0.00319	CbGbCtD
Phenobarbital—Hypoxia—Thiotepa—sarcoma	0.00156	0.0206	CcSEcCtD
Phenobarbital—Necrosis—Dactinomycin—sarcoma	0.00125	0.0166	CcSEcCtD
Phenobarbital—Nystagmus—Vincristine—sarcoma	0.00123	0.0163	CcSEcCtD
Phenobarbital—Delirium—Thiotepa—sarcoma	0.00115	0.0152	CcSEcCtD
Phenobarbital—Extravasation—Thiotepa—sarcoma	0.00113	0.015	CcSEcCtD
Phenobarbital—Extravasation—Dactinomycin—sarcoma	0.00113	0.0149	CcSEcCtD
Phenobarbital—Necrosis—Mitoxantrone—sarcoma	0.00109	0.0144	CcSEcCtD
Phenobarbital—Hypocalcaemia—Dactinomycin—sarcoma	0.00107	0.0142	CcSEcCtD
Phenobarbital—Extravasation—Vincristine—sarcoma	0.00101	0.0133	CcSEcCtD
Phenobarbital—Extravasation—Mitoxantrone—sarcoma	0.00098	0.013	CcSEcCtD
Phenobarbital—Laryngospasm—Etoposide—sarcoma	0.000952	0.0126	CcSEcCtD
Phenobarbital—CYP4B1—cardiac atrium—sarcoma	0.000943	0.0263	CbGeAlD
Phenobarbital—CYP4B1—uterus—sarcoma	0.000938	0.0262	CbGeAlD
Phenobarbital—Hypocalcaemia—Mitoxantrone—sarcoma	0.000934	0.0124	CcSEcCtD
Phenobarbital—GRIA2—embryo—sarcoma	0.000927	0.0259	CbGeAlD
Phenobarbital—Necrosis—Etoposide—sarcoma	0.000906	0.012	CcSEcCtD
Phenobarbital—Respiratory failure—Vincristine—sarcoma	0.000894	0.0118	CcSEcCtD
Phenobarbital—SLCO2A1—myometrium—sarcoma	0.000865	0.0242	CbGeAlD
Phenobarbital—Apnoea—Etoposide—sarcoma	0.000839	0.0111	CcSEcCtD
Phenobarbital—CYP4B1—tendon—sarcoma	0.000822	0.0229	CbGeAlD
Phenobarbital—Extravasation—Etoposide—sarcoma	0.000815	0.0108	CcSEcCtD
Phenobarbital—Coma—Vincristine—sarcoma	0.000802	0.0106	CcSEcCtD
Phenobarbital—SLCO2A1—seminal vesicle—sarcoma	0.000781	0.0218	CbGeAlD
Phenobarbital—CHRFAM7A—hematopoietic system—sarcoma	0.000754	0.0211	CbGeAlD
Phenobarbital—CYP1B1—mammary gland—sarcoma	0.000733	0.0205	CbGeAlD
Phenobarbital—Lethargy—Dactinomycin—sarcoma	0.000728	0.00964	CcSEcCtD
Phenobarbital—CYP4A11—liver—sarcoma	0.000721	0.0201	CbGeAlD
Phenobarbital—Hypothermia—Epirubicin—sarcoma	0.000711	0.00942	CcSEcCtD
Phenobarbital—Body temperature decreased—Epirubicin—sarcoma	0.000711	0.00942	CcSEcCtD
Phenobarbital—CYP4B1—testis—sarcoma	0.00068	0.019	CbGeAlD
Phenobarbital—Ataxia—Thiotepa—sarcoma	0.000675	0.00895	CcSEcCtD
Phenobarbital—Hypothermia—Doxorubicin—sarcoma	0.000658	0.00871	CcSEcCtD
Phenobarbital—Body temperature decreased—Doxorubicin—sarcoma	0.000658	0.00871	CcSEcCtD
Phenobarbital—SLCO2A1—skin of body—sarcoma	0.000646	0.018	CbGeAlD
Phenobarbital—Toxic epidermal necrolysis—Dactinomycin—sarcoma	0.000642	0.00851	CcSEcCtD
Phenobarbital—CYP2A6—seminal vesicle—sarcoma	0.000641	0.0179	CbGeAlD
Phenobarbital—CHRNA7—hematopoietic system—sarcoma	0.000609	0.017	CbGeAlD
Phenobarbital—CHRNA4—hematopoietic system—sarcoma	0.000601	0.0168	CbGeAlD
Phenobarbital—Ataxia—Vincristine—sarcoma	0.000599	0.00794	CcSEcCtD
Phenobarbital—ABCC3—hematopoietic system—sarcoma	0.00057	0.0159	CbGeAlD
Phenobarbital—SLCO2A1—cardiac atrium—sarcoma	0.000564	0.0157	CbGeAlD
Phenobarbital—CYP2C8—mammary gland—sarcoma	0.000561	0.0157	CbGeAlD
Phenobarbital—SLCO2A1—uterus—sarcoma	0.000561	0.0157	CbGeAlD
Phenobarbital—Nystagmus—Epirubicin—sarcoma	0.000558	0.00739	CcSEcCtD
Phenobarbital—Blister—Epirubicin—sarcoma	0.000553	0.00732	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Dactinomycin—sarcoma	0.000545	0.00722	CcSEcCtD
Phenobarbital—Renal failure—Thiotepa—sarcoma	0.000544	0.00721	CcSEcCtD
Phenobarbital—CHRNA7—skin of body—sarcoma	0.00053	0.0148	CbGeAlD
Phenobarbital—Nystagmus—Doxorubicin—sarcoma	0.000516	0.00684	CcSEcCtD
Phenobarbital—Blister—Doxorubicin—sarcoma	0.000512	0.00678	CcSEcCtD
Phenobarbital—Necrosis—Epirubicin—sarcoma	0.000508	0.00673	CcSEcCtD
Phenobarbital—CYP2C9—mammary gland—sarcoma	0.000498	0.0139	CbGeAlD
Phenobarbital—Hallucination—Thiotepa—sarcoma	0.000494	0.00655	CcSEcCtD
Phenobarbital—Hepatitis—Dactinomycin—sarcoma	0.000493	0.00653	CcSEcCtD
Phenobarbital—CYP4B1—lymph node—sarcoma	0.000493	0.0138	CbGeAlD
Phenobarbital—SLCO2A1—tendon—sarcoma	0.000491	0.0137	CbGeAlD
Phenobarbital—ABCB11—testis—sarcoma	0.000491	0.0137	CbGeAlD
Phenobarbital—Drowsiness—Mitoxantrone—sarcoma	0.000478	0.00633	CcSEcCtD
Phenobarbital—CYP2C18—liver—sarcoma	0.000477	0.0133	CbGeAlD
Phenobarbital—Liver injury—Epirubicin—sarcoma	0.000474	0.00627	CcSEcCtD
Phenobarbital—Renal failure—Mitoxantrone—sarcoma	0.00047	0.00623	CcSEcCtD
Phenobarbital—Necrosis—Doxorubicin—sarcoma	0.00047	0.00622	CcSEcCtD
Phenobarbital—ABCC1—myometrium—sarcoma	0.000468	0.0131	CbGeAlD
Phenobarbital—Erythema multiforme—Dactinomycin—sarcoma	0.000466	0.00618	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Etoposide—sarcoma	0.000465	0.00616	CcSEcCtD
Phenobarbital—ABCB11—liver—sarcoma	0.000464	0.013	CbGeAlD
Phenobarbital—Delirium—Epirubicin—sarcoma	0.000463	0.00614	CcSEcCtD
Phenobarbital—CHRNA7—uterus—sarcoma	0.00046	0.0129	CbGeAlD
Phenobarbital—Extravasation—Epirubicin—sarcoma	0.000457	0.00605	CcSEcCtD
Phenobarbital—CYP3A7—liver—sarcoma	0.000454	0.0127	CbGeAlD
Phenobarbital—GRIA2—testis—sarcoma	0.000454	0.0127	CbGeAlD
Phenobarbital—CYP1B1—hematopoietic system—sarcoma	0.000446	0.0125	CbGeAlD
Phenobarbital—Hallucination—Vincristine—sarcoma	0.000438	0.00581	CcSEcCtD
Phenobarbital—Liver injury—Doxorubicin—sarcoma	0.000438	0.0058	CcSEcCtD
Phenobarbital—Bradycardia—Mitoxantrone—sarcoma	0.000437	0.00579	CcSEcCtD
Phenobarbital—Thinking abnormal—Epirubicin—sarcoma	0.000435	0.00577	CcSEcCtD
Phenobarbital—Hypocalcaemia—Epirubicin—sarcoma	0.000435	0.00577	CcSEcCtD
Phenobarbital—Erythema—Thiotepa—sarcoma	0.000433	0.00573	CcSEcCtD
Phenobarbital—CYP1B1—connective tissue—sarcoma	0.00043	0.012	CbGeAlD
Phenobarbital—Erythema—Dactinomycin—sarcoma	0.000429	0.00569	CcSEcCtD
Phenobarbital—Hepatitis—Mitoxantrone—sarcoma	0.000429	0.00569	CcSEcCtD
Phenobarbital—Delirium—Doxorubicin—sarcoma	0.000429	0.00568	CcSEcCtD
Phenobarbital—Tension—Thiotepa—sarcoma	0.000425	0.00562	CcSEcCtD
Phenobarbital—Extravasation—Doxorubicin—sarcoma	0.000423	0.0056	CcSEcCtD
Phenobarbital—ABCC1—seminal vesicle—sarcoma	0.000422	0.0118	CbGeAlD
Phenobarbital—Nervousness—Thiotepa—sarcoma	0.00042	0.00557	CcSEcCtD
Phenobarbital—CHRFAM7A—testis—sarcoma	0.000413	0.0115	CbGeAlD
Phenobarbital—SLCO2A1—testis—sarcoma	0.000407	0.0114	CbGeAlD
Phenobarbital—Thinking abnormal—Doxorubicin—sarcoma	0.000403	0.00534	CcSEcCtD
Phenobarbital—Hypocalcaemia—Doxorubicin—sarcoma	0.000403	0.00534	CcSEcCtD
Phenobarbital—Hepatocellular injury—Epirubicin—sarcoma	0.000398	0.00528	CcSEcCtD
Phenobarbital—Agitation—Thiotepa—sarcoma	0.000398	0.00527	CcSEcCtD
Phenobarbital—Injection site reaction—Epirubicin—sarcoma	0.000396	0.00525	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Etoposide—sarcoma	0.000394	0.00522	CcSEcCtD
Phenobarbital—CYP1B1—smooth muscle tissue—sarcoma	0.000393	0.011	CbGeAlD
Phenobarbital—CYP2C19—hematopoietic system—sarcoma	0.000392	0.0109	CbGeAlD
Phenobarbital—Renal failure—Etoposide—sarcoma	0.000391	0.00518	CcSEcCtD
Phenobarbital—CYP1B1—skin of body—sarcoma	0.000388	0.0108	CbGeAlD
Phenobarbital—CYP3A7-CYP3A51P—liver—sarcoma	0.000386	0.0108	CbGeAlD
Phenobarbital—SLCO2A1—liver—sarcoma	0.000385	0.0107	CbGeAlD
Phenobarbital—Erythema—Mitoxantrone—sarcoma	0.000374	0.00495	CcSEcCtD
Phenobarbital—Hepatocellular injury—Doxorubicin—sarcoma	0.000369	0.00488	CcSEcCtD
Phenobarbital—Myalgia—Thiotepa—sarcoma	0.000368	0.00488	CcSEcCtD
Phenobarbital—Arthralgia—Thiotepa—sarcoma	0.000368	0.00488	CcSEcCtD
Phenobarbital—Anxiety—Thiotepa—sarcoma	0.000367	0.00486	CcSEcCtD
Phenobarbital—Injection site reaction—Doxorubicin—sarcoma	0.000367	0.00486	CcSEcCtD
Phenobarbital—Myalgia—Dactinomycin—sarcoma	0.000366	0.00484	CcSEcCtD
Phenobarbital—Coma—Epirubicin—sarcoma	0.000364	0.00482	CcSEcCtD
Phenobarbital—Confusional state—Thiotepa—sarcoma	0.000356	0.00472	CcSEcCtD
Phenobarbital—Agitation—Vincristine—sarcoma	0.000353	0.00467	CcSEcCtD
Phenobarbital—Mental disability—Epirubicin—sarcoma	0.000346	0.00458	CcSEcCtD
Phenobarbital—Vertigo—Vincristine—sarcoma	0.000345	0.00457	CcSEcCtD
Phenobarbital—CYP2C8—hematopoietic system—sarcoma	0.000342	0.00955	CbGeAlD
Phenobarbital—Erythema multiforme—Etoposide—sarcoma	0.000338	0.00447	CcSEcCtD
Phenobarbital—CYP1B1—uterus—sarcoma	0.000337	0.00942	CbGeAlD
Phenobarbital—Coma—Doxorubicin—sarcoma	0.000337	0.00446	CcSEcCtD
Phenobarbital—CHRNA7—testis—sarcoma	0.000334	0.00933	CbGeAlD
Phenobarbital—Myalgia—Vincristine—sarcoma	0.000327	0.00433	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Thiotepa—sarcoma	0.000322	0.00426	CcSEcCtD
Phenobarbital—Mental disability—Doxorubicin—sarcoma	0.00032	0.00424	CcSEcCtD
Phenobarbital—CYP1A2—hematopoietic system—sarcoma	0.00032	0.00893	CbGeAlD
Phenobarbital—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000319	0.00423	CcSEcCtD
Phenobarbital—Arthralgia—Mitoxantrone—sarcoma	0.000318	0.00421	CcSEcCtD
Phenobarbital—Myalgia—Mitoxantrone—sarcoma	0.000318	0.00421	CcSEcCtD
Phenobarbital—Anxiety—Mitoxantrone—sarcoma	0.000317	0.0042	CcSEcCtD
Phenobarbital—CYP1A1—hematopoietic system—sarcoma	0.000315	0.00881	CbGeAlD
Phenobarbital—CYP2A6—liver—sarcoma	0.000315	0.00881	CbGeAlD
Phenobarbital—CYP1B1—lymphoid tissue—sarcoma	0.000314	0.00878	CbGeAlD
Phenobarbital—Somnolence—Thiotepa—sarcoma	0.000314	0.00416	CcSEcCtD
Phenobarbital—ABCC3—testis—sarcoma	0.000313	0.00873	CbGeAlD
Phenobarbital—CYP3A5—hematopoietic system—sarcoma	0.000308	0.00862	CbGeAlD
Phenobarbital—Confusional state—Mitoxantrone—sarcoma	0.000307	0.00407	CcSEcCtD
Phenobarbital—CYP2B6—hematopoietic system—sarcoma	0.000307	0.00856	CbGeAlD
Phenobarbital—Dermatitis exfoliative—Epirubicin—sarcoma	0.000307	0.00406	CcSEcCtD
Phenobarbital—ABCC1—cardiac atrium—sarcoma	0.000305	0.00851	CbGeAlD
Phenobarbital—CYP2C9—hematopoietic system—sarcoma	0.000304	0.00848	CbGeAlD
Phenobarbital—ABCC1—uterus—sarcoma	0.000303	0.00847	CbGeAlD
Phenobarbital—CYP2E1—seminal vesicle—sarcoma	0.000303	0.00846	CbGeAlD
Phenobarbital—Dermatitis bullous—Epirubicin—sarcoma	0.000303	0.00401	CcSEcCtD
Phenobarbital—Pain—Thiotepa—sarcoma	0.000302	0.004	CcSEcCtD
Phenobarbital—Constipation—Thiotepa—sarcoma	0.000302	0.004	CcSEcCtD
Phenobarbital—ABCC2—tendon—sarcoma	0.000302	0.00842	CbGeAlD
Phenobarbital—Shock—Mitoxantrone—sarcoma	0.0003	0.00397	CcSEcCtD
Phenobarbital—Pain—Dactinomycin—sarcoma	0.0003	0.00397	CcSEcCtD
Phenobarbital—ABCC3—liver—sarcoma	0.000295	0.00825	CbGeAlD
Phenobarbital—CYP1B1—tendon—sarcoma	0.000295	0.00825	CbGeAlD
Phenobarbital—Lethargy—Epirubicin—sarcoma	0.000295	0.00391	CcSEcCtD
Phenobarbital—SLCO2A1—lymph node—sarcoma	0.000295	0.00824	CbGeAlD
Phenobarbital—Hypotension—Vincristine—sarcoma	0.000293	0.00388	CcSEcCtD
Phenobarbital—Feeling abnormal—Thiotepa—sarcoma	0.000291	0.00385	CcSEcCtD
Phenobarbital—Feeling abnormal—Dactinomycin—sarcoma	0.000289	0.00383	CcSEcCtD
Phenobarbital—CYP2E1—hematopoietic system—sarcoma	0.000288	0.00804	CbGeAlD
Phenobarbital—Musculoskeletal discomfort—Vincristine—sarcoma	0.000285	0.00378	CcSEcCtD
Phenobarbital—Hypotension—Mitoxantrone—sarcoma	0.000285	0.00377	CcSEcCtD
Phenobarbital—Affect lability—Epirubicin—sarcoma	0.000285	0.00377	CcSEcCtD
Phenobarbital—Dermatitis exfoliative—Doxorubicin—sarcoma	0.000284	0.00376	CcSEcCtD
Phenobarbital—Urticaria—Thiotepa—sarcoma	0.00028	0.00372	CcSEcCtD
Phenobarbital—Dermatitis bullous—Doxorubicin—sarcoma	0.00028	0.00371	CcSEcCtD
Phenobarbital—Vertigo—Etoposide—sarcoma	0.000279	0.0037	CcSEcCtD
Phenobarbital—Body temperature increased—Thiotepa—sarcoma	0.000279	0.0037	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000278	0.00368	CcSEcCtD
Phenobarbital—Body temperature increased—Dactinomycin—sarcoma	0.000277	0.00367	CcSEcCtD
Phenobarbital—CYP1A1—skin of body—sarcoma	0.000274	0.00766	CbGeAlD
Phenobarbital—Mood swings—Epirubicin—sarcoma	0.000274	0.00363	CcSEcCtD
Phenobarbital—Loss of consciousness—Etoposide—sarcoma	0.000273	0.00362	CcSEcCtD
Phenobarbital—Lethargy—Doxorubicin—sarcoma	0.000273	0.00362	CcSEcCtD
Phenobarbital—Ataxia—Epirubicin—sarcoma	0.000272	0.0036	CcSEcCtD
Phenobarbital—Somnolence—Mitoxantrone—sarcoma	0.000271	0.00359	CcSEcCtD
Phenobarbital—Pain—Vincristine—sarcoma	0.000268	0.00355	CcSEcCtD
Phenobarbital—Constipation—Vincristine—sarcoma	0.000268	0.00355	CcSEcCtD
Phenobarbital—CYP2B6—skin of body—sarcoma	0.000267	0.00744	CbGeAlD
Phenobarbital—ABCC1—tendon—sarcoma	0.000266	0.00742	CbGeAlD
Phenobarbital—Affect lability—Doxorubicin—sarcoma	0.000263	0.00349	CcSEcCtD
Phenobarbital—Pain—Mitoxantrone—sarcoma	0.000261	0.00345	CcSEcCtD
Phenobarbital—Constipation—Mitoxantrone—sarcoma	0.000261	0.00345	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.00026	0.00345	CcSEcCtD
Phenobarbital—Hypersensitivity—Thiotepa—sarcoma	0.00026	0.00345	CcSEcCtD
Phenobarbital—Hypersensitivity—Dactinomycin—sarcoma	0.000258	0.00342	CcSEcCtD
Phenobarbital—Confusional state—Etoposide—sarcoma	0.000256	0.00339	CcSEcCtD
Phenobarbital—Mood swings—Doxorubicin—sarcoma	0.000254	0.00336	CcSEcCtD
Phenobarbital—Ataxia—Doxorubicin—sarcoma	0.000252	0.00333	CcSEcCtD
Phenobarbital—Feeling abnormal—Mitoxantrone—sarcoma	0.000251	0.00333	CcSEcCtD
Phenobarbital—Asthma—Epirubicin—sarcoma	0.00025	0.00331	CcSEcCtD
Phenobarbital—ABCC2—testis—sarcoma	0.00025	0.00698	CbGeAlD
Phenobarbital—Body temperature increased—Vincristine—sarcoma	0.000248	0.00328	CcSEcCtD
Phenobarbital—CYP1B1—testis—sarcoma	0.000245	0.00683	CbGeAlD
Phenobarbital—Urticaria—Mitoxantrone—sarcoma	0.000242	0.00321	CcSEcCtD
Phenobarbital—Body temperature increased—Mitoxantrone—sarcoma	0.000241	0.00319	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000241	0.00319	CcSEcCtD
Phenobarbital—CYP1A1—cardiac atrium—sarcoma	0.00024	0.00669	CbGeAlD
Phenobarbital—CYP1A1—uterus—sarcoma	0.000238	0.00666	CbGeAlD
Phenobarbital—Hypotension—Etoposide—sarcoma	0.000237	0.00314	CcSEcCtD
Phenobarbital—ABCC2—liver—sarcoma	0.000236	0.00659	CbGeAlD
Phenobarbital—Dizziness—Thiotepa—sarcoma	0.000233	0.00309	CcSEcCtD
Phenobarbital—CYP3A4—hematopoietic system—sarcoma	0.000232	0.00647	CbGeAlD
Phenobarbital—Asthma—Doxorubicin—sarcoma	0.000231	0.00306	CcSEcCtD
Phenobarbital—CYP1B1—liver—sarcoma	0.000231	0.00646	CbGeAlD
Phenobarbital—Hypersensitivity—Vincristine—sarcoma	0.000231	0.00306	CcSEcCtD
Phenobarbital—ABCC3—lymph node—sarcoma	0.000227	0.00633	CbGeAlD
Phenobarbital—Somnolence—Etoposide—sarcoma	0.000225	0.00299	CcSEcCtD
Phenobarbital—Hypersensitivity—Mitoxantrone—sarcoma	0.000225	0.00298	CcSEcCtD
Phenobarbital—Vomiting—Thiotepa—sarcoma	0.000224	0.00297	CcSEcCtD
Phenobarbital—Drowsiness—Epirubicin—sarcoma	0.000223	0.00295	CcSEcCtD
Phenobarbital—Vomiting—Dactinomycin—sarcoma	0.000223	0.00295	CcSEcCtD
Phenobarbital—Rash—Thiotepa—sarcoma	0.000223	0.00295	CcSEcCtD
Phenobarbital—Dermatitis—Thiotepa—sarcoma	0.000222	0.00295	CcSEcCtD
Phenobarbital—Headache—Thiotepa—sarcoma	0.000221	0.00293	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000221	0.00293	CcSEcCtD
Phenobarbital—Rash—Dactinomycin—sarcoma	0.000221	0.00293	CcSEcCtD
Phenobarbital—ABCC1—testis—sarcoma	0.00022	0.00614	CbGeAlD
Phenobarbital—Renal failure—Epirubicin—sarcoma	0.000219	0.0029	CcSEcCtD
Phenobarbital—Constipation—Etoposide—sarcoma	0.000217	0.00287	CcSEcCtD
Phenobarbital—Pain—Etoposide—sarcoma	0.000217	0.00287	CcSEcCtD
Phenobarbital—CYP2B6—lymphoid tissue—sarcoma	0.000216	0.00603	CbGeAlD
Phenobarbital—Nausea—Thiotepa—sarcoma	0.00021	0.00278	CcSEcCtD
Phenobarbital—Feeling abnormal—Etoposide—sarcoma	0.000209	0.00277	CcSEcCtD
Phenobarbital—Nausea—Dactinomycin—sarcoma	0.000208	0.00276	CcSEcCtD
Phenobarbital—ABCC1—liver—sarcoma	0.000208	0.00581	CbGeAlD
Phenobarbital—Dizziness—Vincristine—sarcoma	0.000207	0.00274	CcSEcCtD
Phenobarbital—Drowsiness—Doxorubicin—sarcoma	0.000206	0.00273	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000204	0.00271	CcSEcCtD
Phenobarbital—Bradycardia—Epirubicin—sarcoma	0.000204	0.0027	CcSEcCtD
Phenobarbital—CYP2C19—liver—sarcoma	0.000203	0.00567	CbGeAlD
Phenobarbital—Renal failure—Doxorubicin—sarcoma	0.000203	0.00269	CcSEcCtD
Phenobarbital—CYP2E1—lymphoid tissue—sarcoma	0.000203	0.00566	CbGeAlD
Phenobarbital—Urticaria—Etoposide—sarcoma	0.000201	0.00267	CcSEcCtD
Phenobarbital—Body temperature increased—Etoposide—sarcoma	0.0002	0.00266	CcSEcCtD
Phenobarbital—Hepatitis—Epirubicin—sarcoma	0.0002	0.00265	CcSEcCtD
Phenobarbital—Vomiting—Vincristine—sarcoma	0.000199	0.00264	CcSEcCtD
Phenobarbital—Rash—Vincristine—sarcoma	0.000197	0.00262	CcSEcCtD
Phenobarbital—Dermatitis—Vincristine—sarcoma	0.000197	0.00261	CcSEcCtD
Phenobarbital—Headache—Vincristine—sarcoma	0.000196	0.0026	CcSEcCtD
Phenobarbital—Vomiting—Mitoxantrone—sarcoma	0.000194	0.00257	CcSEcCtD
Phenobarbital—Rash—Mitoxantrone—sarcoma	0.000192	0.00255	CcSEcCtD
Phenobarbital—Dermatitis—Mitoxantrone—sarcoma	0.000192	0.00254	CcSEcCtD
Phenobarbital—Headache—Mitoxantrone—sarcoma	0.000191	0.00253	CcSEcCtD
Phenobarbital—ABCB1—myometrium—sarcoma	0.000191	0.00533	CbGeAlD
Phenobarbital—CYP2E1—tendon—sarcoma	0.00019	0.00532	CbGeAlD
Phenobarbital—Erythema multiforme—Epirubicin—sarcoma	0.000189	0.00251	CcSEcCtD
Phenobarbital—Bradycardia—Doxorubicin—sarcoma	0.000188	0.0025	CcSEcCtD
Phenobarbital—CYP2C8—testis—sarcoma	0.000187	0.00523	CbGeAlD
Phenobarbital—Hypersensitivity—Etoposide—sarcoma	0.000187	0.00248	CcSEcCtD
Phenobarbital—Nausea—Vincristine—sarcoma	0.000186	0.00246	CcSEcCtD
Phenobarbital—Hepatitis—Doxorubicin—sarcoma	0.000185	0.00245	CcSEcCtD
Phenobarbital—ABCB1—embryo—sarcoma	0.000184	0.00513	CbGeAlD
Phenobarbital—Nausea—Mitoxantrone—sarcoma	0.000181	0.0024	CcSEcCtD
Phenobarbital—ABCC2—lymph node—sarcoma	0.000181	0.00506	CbGeAlD
Phenobarbital—CYP1B1—lymph node—sarcoma	0.000177	0.00495	CbGeAlD
Phenobarbital—CYP2C8—liver—sarcoma	0.000177	0.00495	CbGeAlD
Phenobarbital—Erythema multiforme—Doxorubicin—sarcoma	0.000175	0.00232	CcSEcCtD
Phenobarbital—Erythema—Epirubicin—sarcoma	0.000174	0.00231	CcSEcCtD
Phenobarbital—ABCB1—seminal vesicle—sarcoma	0.000172	0.00482	CbGeAlD
Phenobarbital—Tension—Epirubicin—sarcoma	0.000171	0.00226	CcSEcCtD
Phenobarbital—Nervousness—Epirubicin—sarcoma	0.000169	0.00224	CcSEcCtD
Phenobarbital—CYP2B6—testis—sarcoma	0.000168	0.00469	CbGeAlD
Phenobarbital—Dizziness—Etoposide—sarcoma	0.000168	0.00222	CcSEcCtD
Phenobarbital—CYP1A2—liver—sarcoma	0.000166	0.00463	CbGeAlD
Phenobarbital—ABCB1—hematopoietic system—sarcoma	0.000164	0.00458	CbGeAlD
Phenobarbital—CYP1A1—liver—sarcoma	0.000163	0.00457	CbGeAlD
Phenobarbital—Vomiting—Etoposide—sarcoma	0.000161	0.00214	CcSEcCtD
Phenobarbital—Erythema—Doxorubicin—sarcoma	0.000161	0.00214	CcSEcCtD
Phenobarbital—Agitation—Epirubicin—sarcoma	0.00016	0.00212	CcSEcCtD
Phenobarbital—Rash—Etoposide—sarcoma	0.00016	0.00212	CcSEcCtD
Phenobarbital—CYP3A5—liver—sarcoma	0.00016	0.00446	CbGeAlD
Phenobarbital—Dermatitis—Etoposide—sarcoma	0.00016	0.00212	CcSEcCtD
Phenobarbital—ABCC1—lymph node—sarcoma	0.000159	0.00445	CbGeAlD
Phenobarbital—Headache—Etoposide—sarcoma	0.000159	0.0021	CcSEcCtD
Phenobarbital—CYP2B6—liver—sarcoma	0.000159	0.00444	CbGeAlD
Phenobarbital—Tension—Doxorubicin—sarcoma	0.000158	0.0021	CcSEcCtD
Phenobarbital—CYP2E1—testis—sarcoma	0.000158	0.0044	CbGeAlD
Phenobarbital—CYP2C9—liver—sarcoma	0.000157	0.00439	CbGeAlD
Phenobarbital—Nervousness—Doxorubicin—sarcoma	0.000157	0.00207	CcSEcCtD
Phenobarbital—Vertigo—Epirubicin—sarcoma	0.000157	0.00207	CcSEcCtD
Phenobarbital—Syncope—Epirubicin—sarcoma	0.000156	0.00207	CcSEcCtD
Phenobarbital—Loss of consciousness—Epirubicin—sarcoma	0.000153	0.00203	CcSEcCtD
Phenobarbital—Nausea—Etoposide—sarcoma	0.000151	0.002	CcSEcCtD
Phenobarbital—CYP2E1—liver—sarcoma	0.000149	0.00416	CbGeAlD
Phenobarbital—Myalgia—Epirubicin—sarcoma	0.000148	0.00196	CcSEcCtD
Phenobarbital—Arthralgia—Epirubicin—sarcoma	0.000148	0.00196	CcSEcCtD
Phenobarbital—Agitation—Doxorubicin—sarcoma	0.000148	0.00196	CcSEcCtD
Phenobarbital—Anxiety—Epirubicin—sarcoma	0.000148	0.00196	CcSEcCtD
Phenobarbital—Vertigo—Doxorubicin—sarcoma	0.000145	0.00192	CcSEcCtD
Phenobarbital—Syncope—Doxorubicin—sarcoma	0.000145	0.00191	CcSEcCtD
Phenobarbital—Confusional state—Epirubicin—sarcoma	0.000143	0.0019	CcSEcCtD
Phenobarbital—Loss of consciousness—Doxorubicin—sarcoma	0.000142	0.00188	CcSEcCtD
Phenobarbital—Shock—Epirubicin—sarcoma	0.00014	0.00185	CcSEcCtD
Phenobarbital—Myalgia—Doxorubicin—sarcoma	0.000137	0.00182	CcSEcCtD
Phenobarbital—Arthralgia—Doxorubicin—sarcoma	0.000137	0.00182	CcSEcCtD
Phenobarbital—Anxiety—Doxorubicin—sarcoma	0.000137	0.00181	CcSEcCtD
Phenobarbital—Hypotension—Epirubicin—sarcoma	0.000133	0.00176	CcSEcCtD
Phenobarbital—Confusional state—Doxorubicin—sarcoma	0.000133	0.00176	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00013	0.00172	CcSEcCtD
Phenobarbital—Shock—Doxorubicin—sarcoma	0.000129	0.00171	CcSEcCtD
Phenobarbital—Somnolence—Epirubicin—sarcoma	0.000126	0.00167	CcSEcCtD
Phenobarbital—CYP1A1—lymph node—sarcoma	0.000125	0.0035	CbGeAlD
Phenobarbital—ABCB1—uterus—sarcoma	0.000124	0.00346	CbGeAlD
Phenobarbital—Hypotension—Doxorubicin—sarcoma	0.000123	0.00163	CcSEcCtD
Phenobarbital—Constipation—Epirubicin—sarcoma	0.000122	0.00161	CcSEcCtD
Phenobarbital—Pain—Epirubicin—sarcoma	0.000122	0.00161	CcSEcCtD
Phenobarbital—CYP3A4—liver—sarcoma	0.00012	0.00335	CbGeAlD
Phenobarbital—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.00012	0.00159	CcSEcCtD
Phenobarbital—Feeling abnormal—Epirubicin—sarcoma	0.000117	0.00155	CcSEcCtD
Phenobarbital—Somnolence—Doxorubicin—sarcoma	0.000117	0.00155	CcSEcCtD
Phenobarbital—ABCB1—lymphoid tissue—sarcoma	0.000115	0.00322	CbGeAlD
Phenobarbital—Urticaria—Epirubicin—sarcoma	0.000113	0.0015	CcSEcCtD
Phenobarbital—Pain—Doxorubicin—sarcoma	0.000112	0.00149	CcSEcCtD
Phenobarbital—Constipation—Doxorubicin—sarcoma	0.000112	0.00149	CcSEcCtD
Phenobarbital—Body temperature increased—Epirubicin—sarcoma	0.000112	0.00149	CcSEcCtD
Phenobarbital—Feeling abnormal—Doxorubicin—sarcoma	0.000108	0.00144	CcSEcCtD
Phenobarbital—ABCB1—bone marrow—sarcoma	0.000105	0.00293	CbGeAlD
Phenobarbital—Hypersensitivity—Epirubicin—sarcoma	0.000105	0.00139	CcSEcCtD
Phenobarbital—Urticaria—Doxorubicin—sarcoma	0.000105	0.00138	CcSEcCtD
Phenobarbital—Body temperature increased—Doxorubicin—sarcoma	0.000104	0.00138	CcSEcCtD
Phenobarbital—Hypersensitivity—Doxorubicin—sarcoma	9.69e-05	0.00128	CcSEcCtD
Phenobarbital—Dizziness—Epirubicin—sarcoma	9.4e-05	0.00125	CcSEcCtD
Phenobarbital—Vomiting—Epirubicin—sarcoma	9.04e-05	0.0012	CcSEcCtD
Phenobarbital—ABCB1—testis—sarcoma	8.98e-05	0.00251	CbGeAlD
Phenobarbital—Rash—Epirubicin—sarcoma	8.96e-05	0.00119	CcSEcCtD
Phenobarbital—Dermatitis—Epirubicin—sarcoma	8.96e-05	0.00119	CcSEcCtD
Phenobarbital—Headache—Epirubicin—sarcoma	8.91e-05	0.00118	CcSEcCtD
Phenobarbital—Dizziness—Doxorubicin—sarcoma	8.7e-05	0.00115	CcSEcCtD
Phenobarbital—ABCB1—liver—sarcoma	8.49e-05	0.00237	CbGeAlD
Phenobarbital—Nausea—Epirubicin—sarcoma	8.44e-05	0.00112	CcSEcCtD
Phenobarbital—Vomiting—Doxorubicin—sarcoma	8.36e-05	0.00111	CcSEcCtD
Phenobarbital—Rash—Doxorubicin—sarcoma	8.29e-05	0.0011	CcSEcCtD
Phenobarbital—Dermatitis—Doxorubicin—sarcoma	8.29e-05	0.0011	CcSEcCtD
Phenobarbital—Headache—Doxorubicin—sarcoma	8.24e-05	0.00109	CcSEcCtD
Phenobarbital—Nausea—Doxorubicin—sarcoma	7.81e-05	0.00104	CcSEcCtD
Phenobarbital—ABCB1—lymph node—sarcoma	6.51e-05	0.00182	CbGeAlD
